[go: up one dir, main page]

US3853469A - Reagent and method for phosphorus determination - Google Patents

Reagent and method for phosphorus determination Download PDF

Info

Publication number
US3853469A
US3853469A US00284885A US28488572A US3853469A US 3853469 A US3853469 A US 3853469A US 00284885 A US00284885 A US 00284885A US 28488572 A US28488572 A US 28488572A US 3853469 A US3853469 A US 3853469A
Authority
US
United States
Prior art keywords
percent
reagent
present
determining
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00284885A
Inventor
L Morin
J Prox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medico Electronic Inc
Original Assignee
Medico Electronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medico Electronic Inc filed Critical Medico Electronic Inc
Priority to US00284885A priority Critical patent/US3853469A/en
Application granted granted Critical
Publication of US3853469A publication Critical patent/US3853469A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/16—Phosphorus containing
    • Y10T436/166666—Phosphorus containing of inorganic phosphorus compound in body fluid

Definitions

  • ABSTRACT A method and reagent for the determination of inorganic phosphate in biological fluids by reducing molybdiphosphate with a reducing agent, 0- phenylenediamine dihydrochloride, in the presence of a catalyst, dimethylformamide; a preservative, thiourea; a nonionic surfactant stabilizer, and a polyvinylpyrrolidone clarifier, wherein significantly less acidity than heretofore is required.
  • a reducing agent 0- phenylenediamine dihydrochloride
  • This invention relates to a method for the determination of inorganic phosphate in biological fluids; and more particularly, this invention relates to a method for determining inorganic phosphate using phenylenediamine dihydrochloride to reduce molybdiphosphate in the presence of a dipolar aprotic solvent.
  • Another object of this invention is to provide a stable reducing agent. Still another object is to provide a sensitive reducing agent that produces intense color with a small sample.
  • Another object is to provide a reducing agent that requires no heat above ambient temperature. Still another object is to provide a reducing agent that acts rapidly, requiring no more than ten minutes. Another object is to'provide a reducing agent that obeys Beers law. Another object is to provide a reducing agent that requires only low acidity. Still another object is to provide a reducing agent that produces a stable color.
  • Another object of this invention is to provide a catalyst that accelerates the reaction so that the determination requires no more than five minutes.
  • Still another object is to provide a clarifier that will prevent turbidity in direct determinations.
  • this invention involves an acid molybdate reagent for the determination of inorganic phosphate containing less than 30 percent sulfuric acid or its equivalent which is made to contain all or some of the following: o-phenylenediamine (and its salts), a dipolar aprotic solvent, thiourea, a nonionic surfactant, polyvinylpyrrolidone.
  • o-phenylenediamine includes 0- phenylenediamine and salts thereof such as the dihydrochloride.
  • the preferred o-phenylenediamine is ophenylenediamine dihydrochloride.
  • This invention includes a reagent for determining inorganic phosphate in biological fluid which comprises an aqueous solution containing 0.5 to 30 percent of an acid, 0.1 to 2 gram percent of a molybdate salt, and ophenylenediarnine or a salt thereof.
  • the reagent can also contain a dipolar aprotic solvent.
  • o-phenylenediamine dihydrochloride is a superior reducing agent of molybdiphosphate to molybdynenum blue in that it is highly sensitive, fast, requires no heat, requires only low acidity, obeys Beers Law, and produces a stable color in less than ten minutes. From 10 mg percent to 1 gram percent of the reducing agent is used.
  • dipolar aprotic solvents act as catalysts to the reduction of molybdiphosphates to molybdenum blue regardless of the reducing agent used. From 1 to 5 percent of the dipolar aprotic solvent is used.
  • the preferred dipolar aprotic solvent is dimethylformarnide.
  • thiourea is a useful preservative and stabilizer of reducing agents used in the reduction of molybdiphosphate to molybdenum blue.
  • the thiourea is present in an amount between 10 mg percent and 10 gram percent.
  • polyvinylpyrrolidone in conjunction with a nonionic surfactant or a mixture of nonionic surfactants acts as a useful clarifier in inorganic phosphate determination by the acid molybdate method.
  • the nonionic surfactant in addition to its clarifying properties, serves as a color stabilizer of molybdenum blue in the determination of inorganic phosphate by the acid molybdate method.
  • the preferred nonionic surfactant ' is Triton X-l00. From 0.1 to 10 percent of a nonionic surfactant is used; and from 1 to 20 percent of polyvinylpyrrolidone.
  • the reagent in this invention can be prepared by dissolving 0.1 to 2 gram percent of ammonium molybdate (or any other molybdate salt that is phosphate-free) in 0.5 to 30 percent of sulfuric acid, or equivalent of another acid; adding 1 to 20 percent of polyvinylpyrrolidone (preferably its molecular weight is between 10,000 to 160,000), and l to 5 percent dimethylformamide, 0.01 to 10 percent Triton X-100, or its equivalent of another non-ionic surfactant; and finally, adding 10 mg percent to as much as 1 gram percent of ophenylenediamine dihydrochloride and 10 mg percent to 10 gram percent of thiourea.
  • This invention includes the method of determining the inorganic phosphate in biological fluid samples. Upon the addition of biological fluids in the ratio of l/100 to l/25, an intense stable blue color will develop in l to 10 minutes in linear proportion to the phosphate content of the sample.
  • the phosphate concentration may be determined from the increase in absorbance between 500 to 800 nm by means of a colorimeter.
  • the biological fluids tested can be those of man or animal.
  • biological fluids are serum, plasma, urine and spinal fluid.
  • This invention includes a reagent for determining inorganic phosphate in biological fluids which comprises an aqueous solution containing 1 to 5 percent of a dipolar aprotic solvent, 0.5 to 30 percent of an acid, 0.1 to 2 gram percent of a molybdate salt, and mg percent to 1 gram percent of a reducing agent.
  • the reducing agent can be one of the novel reducing agents disclosed herein, such as, o-phenylenediamine dihydrochloride, or other o-phenylenediamine salts, or any suitable reducing agent such as those listed in the prior art section herein, such as stannous chloride, phenylhydrazine, hydroquinone, ferrocyandie, ferrous sulfate, ammonium ferrous sulfate, ascorbic acid, aminonaphtholsulfonic acid, 2,4-diaminophenol, p-methylaminophenol sulfate, hydrazine, and n-phenyl-p-phenylenediamine.
  • the preferred dipolar aprotic solvent is dimethylformamide.
  • This invention includes a reagent for determining inorganic phosphate in biological fluids which comprises an aqueous solution containing 0.5 to 30 percent of an acid, 0.1 to 2 gram percent of a molybdate salt, 10 mg percent to 1 gram percent of a reducing agent, 0.01 to 10 percent of a nonionic surfactant, and 1 to percent of polyvinylpyrrolidone.
  • the reducing agent can be the novel reducing agents disclosed herein or any suitable reducing agent such as those listed in the prior art section herein.
  • the preferred surfactant is Triton X-100.
  • This invention includes the method, along the lines described above, of colorimetrically determining the concentration of the inorganic phosphate in biological fluids by means of measuring the absorbance.
  • This invention includes a reagent for determining inorganic phosphate in biological fluids which comprises an aqueous solution containing 0.5 to 30 percent of an acid, 10 mg percent 1 gram percent of a reducing agent, 0.1 to 2 gram percent of a molybdate salt and 10 mg percent to 10 gram percent (preferably 5 gram percent) of thiourea.
  • the reducing agent can be the novel reducing agents disclosed herein or any suitable reducing agent such as those listed in the prior art section herein.
  • This invention includes the method, along the lines described above, of colorimetrically determining the concentration of the inorganic phosphate in biological fluids by means of measuring the absorbance.
  • the dipolar aprotic solvents act as catalysts for the reduction of molybdiphosphate to molybdenum blue regardless of the reducing agent used.
  • aprotic solvents are almost devoid of acidic or basic properties, for example, aprotic solvents do not interact strongly with acidic solutes, such as carboxylic acids, phenols and mineral acids, or with basic solutes, such as amines and derivatives of quanidine or pyridine. They are comparatively inert in character. Aprotic solvents are not masking or leveling solvents, such as water. Indifferent solvents are other names for aprotic solvents. In general, aprotic solvents are organic compounds.
  • aprotic solvents There are generally two classes of aprotic solvents, but this invention uses those aprotic solvents which are termed dipolar aprotic solvents (and which generally have a high dielectric constant (e) that ranges from about 21 to about 46.5).
  • the preferred aprotic solvent is dimethylformamide.
  • Examples of other aprotic solvents in this class are acetone, acetonitrile, nitrobenzene, nitromethane, methyl sulfoxide, benzonitrile, nitromethane, dimethylacetamide, sulfolane (tetramethylenesulfone), N-methyl formamide, formamide, N-methyl propionamide, dimethyl sulfoxide, diethylformamide, diethylacetimide, diethylsulfoxide, dipropylforrnamide, dipropylacetarnide, dipropylsulfoxide, dimethylpropiamide, dimethylbutyramide, and mixtures thereof.
  • the preferred molybdate salt is ammonium molybdate.
  • useful molybdate salts are cadmium molybdate, cerium molybdate, barium molybdate, lanthanum molybdate, bismuth molybdate, lead molybdate, calcium molybdate, lithium molybdate, magnesium molybdate, potassium molybdate, sodium molybdate and zinc molybdate.
  • the molybdate salt must be phosphate free. From 0.1 to 2 gram percent of molybdate salt is used.
  • the preferred acid is sulfuric acid
  • useful acids are hydrochloric acid, nitric acid, sulfurous acid, nitrous acid, bromoacetic acid, picric acid, bu tyric acid, salicylic acid, oxalic acid, formic acid, tartaric acid, lactic acid, maleic acid, acetic acid, citric acid, benzoic acid, and telluric acid. From 0.5 to 30 percent of acid is used.
  • the preferred nonionic surfactant is Triton X-lOO.
  • examples of other useful nonionic surfactants are the various polyoxyethylene sorbitan esters of fatty acids available under the tradename TWEEN and the nonylphenyl-polyethylene glycol esters available under the tradename BRIJ. From 0.1 to 10 percent of a nonionic surfactant can be used.
  • any suitable colorimeter or spectrophotometer can be used to measure the absorbance.
  • suitable colorimeters are: Coleman, Model 44; Perkin-Elmer, Model 124; the colorimeter disclosed in US. Ser. No. 224,457, applicants: Raymond W. Kiess and Peter H. Stewart, filed: February 8, 1972, assignee: Kiess Instruments, Inc., 8768 S. W. 131st St., Miami, Fla., 33156; and the direct reading colorimeter disclosed in US. Pat. No. 3,561,878, inventor: R. W. Kiess.
  • EXAMPLE 1 For convenience the reagent is prepared into three distinct components.
  • Component A consists of 12 grams of ammonium molybdate brought to 1 liter with 24 percent sulfuric acid.
  • Component B consists of 60 grams of polyvinylpyrrolidone (molecular weight of 40,000), 9.6 ml of dimethylformamide, and 1 ml of Triton X- brought to 1 liter with water.
  • Component C consists of 30 grams of thiourea and 9 grams of ophenylenediarnine dihydrochloride brought to 100 ml with dimethylformamide. To a series of tubes is added 0.5 ml. of Component A, 2.5 ml of Component B, and 0.1 m1 of Component C to give the complete reagent.
  • EXAMPLE 2 The reagent is prepared as in Example 1 and reagent tubes are set up as in Example 1. A set of standard solutions are prepared in pooled human serum and made to contain 1,2, 3,4,5, 6,7, 8, 9 and mg percent of inorganic phosphate. To each tube of reagent is added 0.1 ml of human serum with various levels of phosphate. The results are the same as in Example 1.
  • EXAMPLE 3 The reagent is prepared as in Example 1, except that dimethylformamide is omitted and replaced with water. Standard solutions are tested as in Example 1. An intense stable blue color develops within 10 minutes instead of 5 minutes. The absorbance is found to be linear with the phosphate concentration.
  • EXAMPLE 4 The reagent is prepared as in Example 1, except that ascorbic acid is substituted for o-phenylenediamine dihydrochloride. The procedure is the same as in Example 1. An unstable blue color develops in minutes. The absorbance, although linear with the phosphate concentration, is of about 75 percent reduced intensity when compared with Example 1.
  • EXAMPLE 5 The reagent is prepared as in Example 4, except that dimethylformamide is omitted. The same procedure is followed as in Example 4. An unstable blue color develops in 30 minutes instead of 15 minutes. The absorbance is as in Example 4.
  • EXAMPLE 6 The reagent is prepared as in Example 1, except that p-methylaminophenol sulfate is substituted for ophenylenediamine dihydrochloride. The same procedure as in Example 1 is followed. No color develops.
  • EXAMPLE 7 The reagent is prepared as in Example 6, except that the sulfuric acid is increased from 24 percent to 75 percent. The procedure is the same as in Example 1. A weak green color develops in minutes that is linear with the phosphate concentration.
  • EXAMPLE 8 The reagent is prepared as in Example 1, except that the polyvinylpyrrolidone is omitted. The procedure is then the same as in 1. 1A turbid blue color develops that is unsuitable for measurement of absorbance.
  • EXAMPLE 9 The reagent is prepared as in Example 1 except that Triton -X-100 is omitted. The procedure is the same as in Example 1. A slightly turbid blue color develops that is linear with the phosphate concentration, but which is unstable and continues to darken indefinitely for at least 2 hours.
  • a reagent for determining inorganic phosphate in biological fluid which comprises an aqueous solution containing 0.5 to 30 percent of an acid, 0.1 to 2 gram percent of a molybdate salt, and o-phenylenediamine or a salt thereof.
  • a reagent according to claim 1 whrein the acid is sulfuric acid.
  • a reagent according to claim 10 wherein the nonionic surfactant is Triton X-100.
  • a reagent according to claim 12 wherein the polyvinylpyrrolidone has a molecular weight between 10,000 to 160,000.
  • a method for determining the inorganic phosphates in biological fluids which comprises admixing a sample of biological fluid with the reagent of claim 11, the ratio of the biological fluid to the reagent being between 1:100 and 1:25, and determining the concentration of inorganic phosphate by means of measuring the absorbance.
  • a reagent for determining inorganic phosphate in biological fluids which comprises an aqueous solution containing 0.5 to 30 percent of an acid, mg percent to 1 gram percent of a reducing agent, 0.1 to 2 gram percent of a molybdate salt and 10 mg percent to 10 gram percent of thiourea.
  • a method for determining the inorganic phosphates in biological fluids which comprises admixing a sample of biological fluid with the reagent of claim 25, the ratio of the biological fluid to the reagent being between 11100 and 1:25, and determining the concentration of inorganic phosphate by means of measuring the absorbance.
  • a reagent for determining inorganic phosphate in biological fluids which comprises an aqueous soluton containing 0.5 to 30 percent of an acid, 0.1 to 2 gram percent of a molybdate salt, 10 mg percent to 1 gram percent of a reducing agent and l to 5 percent of a di polar aprotic solvent.
  • a method for determining the inorganic phosphates in biological fluids which comprises admixing a sample of biological fluid with the reagent of claim 27, the ratio of the biological fluid to the reagent being between 1:100 and 1:25, and determining the concentration of inorganic phosphate by means of measuring the absorbance.
  • a reagent for determining inorganic phosphate in biological fluids which comprises an aqueous solution containing 0.5 to 30 percent of an acid, 0.1 to 2 gram percent of a molybdate salt, 10 mg percent to 1 gram percent of a reducing agent, 0.0] to 10 percent of a nonionic surfactant, and 1 to 20 percent of polyvinylpyrrolidone.
  • a method for determining the inorganic phosphates in biological fluids which comprises admixing a sample of biological fluid with the reagent of claim 29, the ratio of the biological fluid to the reagent being between 1:100 and 1:25, and determining the concentration of inorganic phosphate by means of measuring the absorbance.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

A method and reagent for the determination of inorganic phosphate in biological fluids by reducing molybdiphosphate with a reducing agent, o-phenylenediamine dihydrochloride, in the presence of a catalyst, dimethylformamide; a preservative, thiourea; a nonionic surfactant stabilizer, and a polyvinylpyrrolidone clarifier, wherein significantly less acidity than heretofore is required.

Description

United States Patent [191 Morin et al.
[ Dec. 10, 1974 1 REAGENT AND METHOD FOR PHOSPI-IORUS DETERMINATION [75] lnventors: Leo G. Morin; Jerome R. Prox, both of Miami, Fla.
[73] Assignee: Medico Electronic, Inc.,
Indianapolis, Ind.
[22] Filed: Aug. 30, 1972 [21] Appl. No.: 284,885
OTHER PUBLICATIONS R. J. Henry, Clinical Chemistry, Harper & Row, 1964,
N. D. Cheronis, Organic Chemistry, T. Y. Crowell C0., 1947, pp. 561-562.
M. M. Davis, National B ur. Standards Monograph, 105, 1968, pp. 17, 19.
General Aniline & Film Corp., Tech. Bull., 7543-066; 1960, pp. 1, 4.
Primary Examiner-Robert M. Reese Attorney, Agent, or FirmChristen & Sabol 5 7] ABSTRACT A method and reagent for the determination of inorganic phosphate in biological fluids by reducing molybdiphosphate with a reducing agent, 0- phenylenediamine dihydrochloride, in the presence of a catalyst, dimethylformamide; a preservative, thiourea; a nonionic surfactant stabilizer, and a polyvinylpyrrolidone clarifier, wherein significantly less acidity than heretofore is required.
30 Claims, No Drawings REAGENT AND METHOD FOR PHOSPHORUS DETERMINATION BACKGROUND OF THE INVENTION- 1. Field of this Invention This invention relates to a method for the determination of inorganic phosphate in biological fluids; and more particularly, this invention relates to a method for determining inorganic phosphate using phenylenediamine dihydrochloride to reduce molybdiphosphate in the presence of a dipolar aprotic solvent.
2. Prior Art The basis for the determination of inorganic phosphate is that acid molybdates react with phosphate to form heteropoly compounds of molybdiphosphate which are then reduced to molybdenum blue. The various methods in the literature for determining inorganic phosphates differ chiefly in the reducing agent employed. These reducing agents are well known in the art and they have been reviewed by Henry in Clinical Chemistry, (Harper & Row, 1968). Briefly, they are stannous chloride, phenylhydrazine, hydroquinone, ferrocyanide, ferrous sulfate, ammonium ferrous sulfate, ascorbic acid, aminonaphtholsulfonic acid, 2,4- diaminophenol, p-methylaminophenol sulfate, hydrazine, n-phenyl-p-phenylenediamine. All of these reduc' ing agents are not entirely satisfactory. The first three listed are characterized by unstable color, deviation from Beers Law, great sensitivity to change in acidity, and instability of the reducing agent itself. The next four obey Beers Law, but are slow acting and lack sensitivity. The remainder lack sensitivity. The remainder lack sensitivity, require high acidity (which results in elevated values due to hydrolysis of organic phosphates), and require elevated temperatures. All require at least 30 minutes. It is desirable to have a reducing agent that is stable, is fast acting, requiring no more than 5 minutes, sensitive, obeys Beers Law, requires no heating, requires low acidity, and produces stable color.
BROAD DESCRIPTION OF THE INVENTION It is a primary object of this invention to provide for I a significant improvement of the acid molybdate method for the determination of inorganic phosphate.
Another object of this invention is to provide a stable reducing agent. Still another object is to provide a sensitive reducing agent that produces intense color with a small sample.
Another object is to provide a reducing agent that requires no heat above ambient temperature. Still another object is to provide a reducing agent that acts rapidly, requiring no more than ten minutes. Another object is to'provide a reducing agent that obeys Beers law. Another object is to provide a reducing agent that requires only low acidity. Still another object is to provide a reducing agent that produces a stable color.
Another object of this invention is to provide a catalyst that accelerates the reaction so that the determination requires no more than five minutes.
Still another object is to provide a clarifier that will prevent turbidity in direct determinations.
Other objects and advantages of this invention will become more apparent from the following description.
Broadly, this invention involves an acid molybdate reagent for the determination of inorganic phosphate containing less than 30 percent sulfuric acid or its equivalent which is made to contain all or some of the following: o-phenylenediamine (and its salts), a dipolar aprotic solvent, thiourea, a nonionic surfactant, polyvinylpyrrolidone.
The term o-phenylenediamine includes 0- phenylenediamine and salts thereof such as the dihydrochloride. The preferred o-phenylenediamine is ophenylenediamine dihydrochloride.
This invention includes a reagent for determining inorganic phosphate in biological fluid which comprises an aqueous solution containing 0.5 to 30 percent of an acid, 0.1 to 2 gram percent of a molybdate salt, and ophenylenediarnine or a salt thereof. The reagent can also contain a dipolar aprotic solvent.
It has been found that o-phenylenediamine dihydrochloride is a superior reducing agent of molybdiphosphate to molybdynenum blue in that it is highly sensitive, fast, requires no heat, requires only low acidity, obeys Beers Law, and produces a stable color in less than ten minutes. From 10 mg percent to 1 gram percent of the reducing agent is used.
It has been further found that dipolar aprotic solvents act as catalysts to the reduction of molybdiphosphates to molybdenum blue regardless of the reducing agent used. From 1 to 5 percent of the dipolar aprotic solvent is used. The preferred dipolar aprotic solvent is dimethylformarnide.
It has been further determined that thiourea is a useful preservative and stabilizer of reducing agents used in the reduction of molybdiphosphate to molybdenum blue. The thiourea is present in an amount between 10 mg percent and 10 gram percent.
It has also been found that polyvinylpyrrolidone in conjunction with a nonionic surfactant or a mixture of nonionic surfactants acts as a useful clarifier in inorganic phosphate determination by the acid molybdate method. It has further been found that the nonionic surfactant, in addition to its clarifying properties, serves as a color stabilizer of molybdenum blue in the determination of inorganic phosphate by the acid molybdate method. The preferred nonionic surfactant 'is Triton X-l00. From 0.1 to 10 percent of a nonionic surfactant is used; and from 1 to 20 percent of polyvinylpyrrolidone.
The reagent in this invention can be prepared by dissolving 0.1 to 2 gram percent of ammonium molybdate (or any other molybdate salt that is phosphate-free) in 0.5 to 30 percent of sulfuric acid, or equivalent of another acid; adding 1 to 20 percent of polyvinylpyrrolidone (preferably its molecular weight is between 10,000 to 160,000), and l to 5 percent dimethylformamide, 0.01 to 10 percent Triton X-100, or its equivalent of another non-ionic surfactant; and finally, adding 10 mg percent to as much as 1 gram percent of ophenylenediamine dihydrochloride and 10 mg percent to 10 gram percent of thiourea.
This invention includes the method of determining the inorganic phosphate in biological fluid samples. Upon the addition of biological fluids in the ratio of l/100 to l/25, an intense stable blue color will develop in l to 10 minutes in linear proportion to the phosphate content of the sample. The phosphate concentration may be determined from the increase in absorbance between 500 to 800 nm by means of a colorimeter.
The biological fluids tested can be those of man or animal. Examples of biological fluids are serum, plasma, urine and spinal fluid.
This invention includes a reagent for determining inorganic phosphate in biological fluids which comprises an aqueous solution containing 1 to 5 percent of a dipolar aprotic solvent, 0.5 to 30 percent of an acid, 0.1 to 2 gram percent of a molybdate salt, and mg percent to 1 gram percent of a reducing agent. The reducing agent can be one of the novel reducing agents disclosed herein, such as, o-phenylenediamine dihydrochloride, or other o-phenylenediamine salts, or any suitable reducing agent such as those listed in the prior art section herein, such as stannous chloride, phenylhydrazine, hydroquinone, ferrocyandie, ferrous sulfate, ammonium ferrous sulfate, ascorbic acid, aminonaphtholsulfonic acid, 2,4-diaminophenol, p-methylaminophenol sulfate, hydrazine, and n-phenyl-p-phenylenediamine. The preferred dipolar aprotic solvent is dimethylformamide. This invention includes the method, along the lines described above, of colorimetrically determining the concentration of the inorganic phosphate in biological fluids by means of measuring the absorbance.
This invention includes a reagent for determining inorganic phosphate in biological fluids which comprises an aqueous solution containing 0.5 to 30 percent of an acid, 0.1 to 2 gram percent of a molybdate salt, 10 mg percent to 1 gram percent of a reducing agent, 0.01 to 10 percent of a nonionic surfactant, and 1 to percent of polyvinylpyrrolidone. The reducing agent can be the novel reducing agents disclosed herein or any suitable reducing agent such as those listed in the prior art section herein. The preferred surfactant is Triton X-100. This invention includes the method, along the lines described above, of colorimetrically determining the concentration of the inorganic phosphate in biological fluids by means of measuring the absorbance.
This invention includes a reagent for determining inorganic phosphate in biological fluids which comprises an aqueous solution containing 0.5 to 30 percent of an acid, 10 mg percent 1 gram percent of a reducing agent, 0.1 to 2 gram percent of a molybdate salt and 10 mg percent to 10 gram percent (preferably 5 gram percent) of thiourea. The reducing agent can be the novel reducing agents disclosed herein or any suitable reducing agent such as those listed in the prior art section herein. This invention includes the method, along the lines described above, of colorimetrically determining the concentration of the inorganic phosphate in biological fluids by means of measuring the absorbance.
DETAILED DESCRIPTION OF THE INVENTION The dipolar aprotic solvents act as catalysts for the reduction of molybdiphosphate to molybdenum blue regardless of the reducing agent used.
Monograph 105 of the National Bureau of Standards defines dipolar aprotic solvents. Aprotic solvents are almost devoid of acidic or basic properties, for example, aprotic solvents do not interact strongly with acidic solutes, such as carboxylic acids, phenols and mineral acids, or with basic solutes, such as amines and derivatives of quanidine or pyridine. They are comparatively inert in character. Aprotic solvents are not masking or leveling solvents, such as water. Indifferent solvents are other names for aprotic solvents. In general, aprotic solvents are organic compounds.
There are generally two classes of aprotic solvents, but this invention uses those aprotic solvents which are termed dipolar aprotic solvents (and which generally have a high dielectric constant (e) that ranges from about 21 to about 46.5). The preferred aprotic solvent is dimethylformamide. Examples of other aprotic solvents in this class are acetone, acetonitrile, nitrobenzene, nitromethane, methyl sulfoxide, benzonitrile, nitromethane, dimethylacetamide, sulfolane (tetramethylenesulfone), N-methyl formamide, formamide, N-methyl propionamide, dimethyl sulfoxide, diethylformamide, diethylacetimide, diethylsulfoxide, dipropylforrnamide, dipropylacetarnide, dipropylsulfoxide, dimethylpropiamide, dimethylbutyramide, and mixtures thereof.
The preferred molybdate salt is ammonium molybdate. Examples of useful molybdate salts are cadmium molybdate, cerium molybdate, barium molybdate, lanthanum molybdate, bismuth molybdate, lead molybdate, calcium molybdate, lithium molybdate, magnesium molybdate, potassium molybdate, sodium molybdate and zinc molybdate. The molybdate salt must be phosphate free. From 0.1 to 2 gram percent of molybdate salt is used.
The preferred acid is sulfuric acid, Examples of useful acids are hydrochloric acid, nitric acid, sulfurous acid, nitrous acid, bromoacetic acid, picric acid, bu tyric acid, salicylic acid, oxalic acid, formic acid, tartaric acid, lactic acid, maleic acid, acetic acid, citric acid, benzoic acid, and telluric acid. From 0.5 to 30 percent of acid is used.
The preferred nonionic surfactant is Triton X-lOO. Examples of other useful nonionic surfactants are the various polyoxyethylene sorbitan esters of fatty acids available under the tradename TWEEN and the nonylphenyl-polyethylene glycol esters available under the tradename BRIJ. From 0.1 to 10 percent of a nonionic surfactant can be used.
Any suitable colorimeter or spectrophotometer can be used to measure the absorbance. Examples of useful colorimeters are: Coleman, Model 44; Perkin-Elmer, Model 124; the colorimeter disclosed in US. Ser. No. 224,457, applicants: Raymond W. Kiess and Peter H. Stewart, filed: February 8, 1972, assignee: Kiess Instruments, Inc., 8768 S. W. 131st St., Miami, Fla., 33156; and the direct reading colorimeter disclosed in US. Pat. No. 3,561,878, inventor: R. W. Kiess.
The following examples further illustrate the invention but they do not limit it:
EXAMPLE 1 For convenience the reagent is prepared into three distinct components. Component A consists of 12 grams of ammonium molybdate brought to 1 liter with 24 percent sulfuric acid. Component B consists of 60 grams of polyvinylpyrrolidone (molecular weight of 40,000), 9.6 ml of dimethylformamide, and 1 ml of Triton X- brought to 1 liter with water. Component C consists of 30 grams of thiourea and 9 grams of ophenylenediarnine dihydrochloride brought to 100 ml with dimethylformamide. To a series of tubes is added 0.5 ml. of Component A, 2.5 ml of Component B, and 0.1 m1 of Component C to give the complete reagent.
EXAMPLE 2 The reagent is prepared as in Example 1 and reagent tubes are set up as in Example 1. A set of standard solutions are prepared in pooled human serum and made to contain 1,2, 3,4,5, 6,7, 8, 9 and mg percent of inorganic phosphate. To each tube of reagent is added 0.1 ml of human serum with various levels of phosphate. The results are the same as in Example 1.
EXAMPLE 3 The reagent is prepared as in Example 1, except that dimethylformamide is omitted and replaced with water. Standard solutions are tested as in Example 1. An intense stable blue color develops within 10 minutes instead of 5 minutes. The absorbance is found to be linear with the phosphate concentration.
EXAMPLE 4 The reagent is prepared as in Example 1, except that ascorbic acid is substituted for o-phenylenediamine dihydrochloride. The procedure is the same as in Example 1. An unstable blue color develops in minutes. The absorbance, although linear with the phosphate concentration, is of about 75 percent reduced intensity when compared with Example 1.
EXAMPLE 5 The reagent is prepared as in Example 4, except that dimethylformamide is omitted. The same procedure is followed as in Example 4. An unstable blue color develops in 30 minutes instead of 15 minutes. The absorbance is as in Example 4.
EXAMPLE 6 The reagent is prepared as in Example 1, except that p-methylaminophenol sulfate is substituted for ophenylenediamine dihydrochloride. The same procedure as in Example 1 is followed. No color develops.
EXAMPLE 7 The reagent is prepared as in Example 6, except that the sulfuric acid is increased from 24 percent to 75 percent. The procedure is the same as in Example 1. A weak green color develops in minutes that is linear with the phosphate concentration.
EXAMPLE 8 The reagent is prepared as in Example 1, except that the polyvinylpyrrolidone is omitted. The procedure is then the same as in 1. 1A turbid blue color develops that is unsuitable for measurement of absorbance.
EXAMPLE 9 The reagent is prepared as in Example 1 except that Triton -X-100 is omitted. The procedure is the same as in Example 1. A slightly turbid blue color develops that is linear with the phosphate concentration, but which is unstable and continues to darken indefinitely for at least 2 hours.
What is claimed is:
1. A reagent for determining inorganic phosphate in biological fluid which comprises an aqueous solution containing 0.5 to 30 percent of an acid, 0.1 to 2 gram percent of a molybdate salt, and o-phenylenediamine or a salt thereof.
2. A reagent according to claim 1 whrein the acid is sulfuric acid.
3. A reagent according to claim 1 wherein a dipolar aprotic solvent is present.
4. A reagent according to claim 3 wherein ophenylenediamine or salt thereof is present at a level between 10 mg percent to 1 gram percent.
5. A reagent according to claim 3 wherein the ophenylenediamine or salt thereof is ophenylenediarnine dihydrochloride.
6. A reagent according to claim 3 wherein the dipolar aprotic solvent is present at a level of l to 5 percent. I
7. A reagent according to claim 3 wherein the dipolar aprotic solvent is dimethylformamide,
8. A reagent according to claim 3 wherein thiourea is present at a level between 10 mg percent to 10 gram percent.
9. A reagent according to claim 3 wherein thiourea is present, wherein a nonionic surfactant is present, and wherein polyvinylpyrrolidone is present.
10. A reagent according to claim 3 wherein a nonionic surfactant is present in an amount between 0.01 to 10 percent.
1 l. A reagent according to claim 10 wherein the nonionic surfactant is Triton X-100.
12. A reagent according to claim 3 wherein polyvinylpyrrolidone is present at a level between 1 to 20 percent.
13. A reagent according to claim 12 wherein the polyvinylpyrrolidone has a molecular weight between 10,000 to 160,000.
14. A method for determining the inorganic phosphates in biological fluids which comprises admixing a sample of biological fluid with the reagent of claim 11, the ratio of the biological fluid to the reagent being between 1:100 and 1:25, and determining the concentration of inorganic phosphate by means of measuring the absorbance.
15. A method according to claim 14 wherein the ophenylenediarnine or salt thereof is present at a level between 10 mg percent to 1 gram percent.
16. A method according to claim 14 wherein the ophenylenediamine salt is o-phenylenediamine dihydrochloride.
17. A method according to claim 14 wherein thiourea is present, wherein a nonionic surfactant is present, and wherein polyvinylpyrrolidone is present.
18. A method according to claim 14 wherein the acid is sulfuric acid.
19. A method according to claim 14 wherein the absorbance is measured at a point between 500 and 800 20. A method according to claim 19 wherein thiourea is present at a level between 10 mg percent to 10 gram percent.
21. A method according to claim 19 wherein a nonionic surfactant is present in an amount between 0.1 to 10 percent.
22. A method according to claim 19 wherein polyvinylpyrrolidone is present at a level between 1 to 20 percent.
23. A method according to claim 19 wherein a dipolar aprotic is present at a level of l to percent.
24. A method according to claim 23 wherein the dipolar aprotic solvent is dimethylformamide.
25. A reagent for determining inorganic phosphate in biological fluids which comprises an aqueous solution containing 0.5 to 30 percent of an acid, mg percent to 1 gram percent of a reducing agent, 0.1 to 2 gram percent of a molybdate salt and 10 mg percent to 10 gram percent of thiourea.
26. A method for determining the inorganic phosphates in biological fluids which comprises admixing a sample of biological fluid with the reagent of claim 25, the ratio of the biological fluid to the reagent being between 11100 and 1:25, and determining the concentration of inorganic phosphate by means of measuring the absorbance.
27. A reagent for determining inorganic phosphate in biological fluids which comprises an aqueous soluton containing 0.5 to 30 percent of an acid, 0.1 to 2 gram percent of a molybdate salt, 10 mg percent to 1 gram percent of a reducing agent and l to 5 percent of a di polar aprotic solvent.
28. A method for determining the inorganic phosphates in biological fluids which comprises admixing a sample of biological fluid with the reagent of claim 27, the ratio of the biological fluid to the reagent being between 1:100 and 1:25, and determining the concentration of inorganic phosphate by means of measuring the absorbance.
29. A reagent for determining inorganic phosphate in biological fluids which comprises an aqueous solution containing 0.5 to 30 percent of an acid, 0.1 to 2 gram percent of a molybdate salt, 10 mg percent to 1 gram percent of a reducing agent, 0.0] to 10 percent of a nonionic surfactant, and 1 to 20 percent of polyvinylpyrrolidone.
30. A method for determining the inorganic phosphates in biological fluids which comprises admixing a sample of biological fluid with the reagent of claim 29, the ratio of the biological fluid to the reagent being between 1:100 and 1:25, and determining the concentration of inorganic phosphate by means of measuring the absorbance.

Claims (30)

1. A REAGENT FOR DETERMINING INORGANIC PHOSPHATE IN BIOLOGICAL FLUID WHICH COMPRISES AN AQUEOUS SOLUTION CONTAINING 0.5 TO 30 PERCENT OF AN ACID, 0.1 TO 2 GRAM PERCENT OF A MOLYBDATE SALT, AND O-PENHYLENEDIAMINE OR A SALT THEREOF.
2. A reagent according to claim 1 whrein the acid is sulfuric acid.
3. A reagent according to claim 1 wherein a dipolar aprotic solvent is present.
4. A reagent according to claim 3 wherein o-phenylenediamine or salt thereof is present at a level between 10 mg percent to 1 gram percent.
5. A reagent according to claim 3 wherein the o-phenylenediamine or salt thereof is o-phenylenediamine dihydrochloride.
6. A reagent according to claim 3 wherein the dipolar aprotic solvent is present at a level of 1 to 5 percent.
7. A reagent according to claim 3 wherein the dipolar aprotic solvent is dimethylformamide.
8. A reagent according to claim 3 wherein thiourea is present at a level between 10 mg percent to 10 gram percent.
9. A reagent according to claim 3 wherein thiourea is present, wherein a nonionic surfactant is present, and wherein polyvinylpyrrolidone is present.
10. A reagent according to claim 3 wherein a nonionic surfactant is present in an amount between 0.01 to 10 percent.
11. A reagent according to claim 10 wherein the nonionic surfactant is Triton X-100.
12. A reagent according to claim 3 wherein polyvinylpyrrolidone is present at a level between 1 to 20 percent.
13. A reagent according to claim 12 wherein the polyvinylpyrrolidone has a molecular weight between 10,000 to 160,000.
14. A method for determining the inorganic phosphates in biological fluids which comprises admixing a sample of biological fluid with the reagent of claim 1, the ratio of the biological fluid to the reagent being between 1:100 and 1:25, and determining the concentration of inorganic phosphate by means of measuring the absorbance.
15. A method according to claim 14 wherein the o-phenylenediamine or salt thereof is present at a level between 10 mg percent to 1 gram percent.
16. A method according to claim 14 wherein the o-phenylenediamine salt is o-phenylenediamine dihydrochloride.
17. A method according to claim 14 wherein thiourea is present, wherein a nonionic surfactant is present, and wherein polyvinylpyrrolidone is present.
18. A method according to claim 14 wherein the acid is sulfuric acid.
19. A method according to claim 14 wherein the absorbance is measured at a point between 500 and 800 nm.
20. A method according to claim 19 wherein thiourea is present at a level between 10 mg percent to 10 gram percent.
21. A method according to claim 19 wherein a nonionic surfactant is present in an amount between 0.1 to 10 percent.
22. A method according to claim 19 wherein polyvinylpyrrolidone is present at a level between 1 to 20 percent.
23. A method according to claim 19 wherein a dipolar aprotic is present at a level of 1 to 5 percent.
24. A method according to claim 23 wherein the dipolar aprotic solvent is dimethylformamide.
25. A reagent for determining inorganic phosphate in biological fluids which comprises an aqueous solution containing 0.5 to 30 percent of an acid, 10 mg percent to 1 gram percent of a reducing agent, 0.1 to 2 gram percent of a molybdate salt and 10 mg percent to 10 gram percent of thiourea.
26. A method for determining the inorganic phosphates in biological fluids which comprises admixing a sample of biological fluid with the reagent of claim 25, the ratio of the biological fluid to the reagent being between 1:100 and 1:25, and determining the concentration of inorganic phosphate by means of measuring the absorbance.
27. A reagent for determining inorganic phosphate in biological fluids which comprises an aqueous soluton containing 0.5 to 30 percent of an acid, 0.1 to 2 gram percent of a molybdate salt, 10 mg percent to 1 gram percent of a reducing agent and 1 to 5 percent of a dipolar aprotic solvent.
28. A method for determining the inorganic phosphates in biological fluids which comprises admixing a sample of biological fluid with the reagent of claim 27, the ratio of the biological fluid to the reagent being between 1:100 and 1:25, and determining the concentration of inorganic phosphate by means of measuring the absorbance.
29. A reagent for determining inorganic phosphate in biological fluids which comprises an aqueous solution containing 0.5 to 30 percent of an acid, 0.1 to 2 gram percent of a molybdate salt, 10 mg percent to 1 gram percent of a reducing agent, 0.01 to 10 percent of a nonionic surfactant, and 1 to 20 percent of polyvinylpyrrolidone.
30. A method for determining the inorganic phosphates in biological fluids which comprises admixing a sample of biological fluid with the reagent of claim 29, the ratio of the biological fluid to the reagent being between 1:100 and 1:25, and determining the concentration of inorganic phosphate by means of measuring the absorbance.
US00284885A 1972-08-30 1972-08-30 Reagent and method for phosphorus determination Expired - Lifetime US3853469A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US00284885A US3853469A (en) 1972-08-30 1972-08-30 Reagent and method for phosphorus determination

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00284885A US3853469A (en) 1972-08-30 1972-08-30 Reagent and method for phosphorus determination

Publications (1)

Publication Number Publication Date
US3853469A true US3853469A (en) 1974-12-10

Family

ID=23091893

Family Applications (1)

Application Number Title Priority Date Filing Date
US00284885A Expired - Lifetime US3853469A (en) 1972-08-30 1972-08-30 Reagent and method for phosphorus determination

Country Status (1)

Country Link
US (1) US3853469A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953359A (en) * 1974-04-23 1976-04-27 Pierce Chemical Company Determination of phosphorus
US4220451A (en) * 1979-01-23 1980-09-02 Union Carbide Corporation Process for the determination of serum inorganic phosphate
US4447544A (en) * 1982-07-22 1984-05-08 Instrumentation Laboratory Inc. Method and reagent for determining inorganic phosphate in biological sample
US4731331A (en) * 1984-04-09 1988-03-15 Beckman Instruments, Inc. Rate method for the determination of inorganic phosphorus
US4826773A (en) * 1988-07-18 1989-05-02 Hoffmann-La Roche Inc. Method and reagent for the quantitative determination of phosphorous in serum and urine
EP0404590A3 (en) * 1989-06-22 1991-10-23 Technicon Gmbh Method of and reagent for the prevention of turbidity
CN102879345A (en) * 2012-09-26 2013-01-16 攀钢集团江油长城特殊钢有限公司 Method for determining phosphorus content of silicon ferrovanadium
CN104237216A (en) * 2014-06-11 2014-12-24 武汉钢铁(集团)公司 Method for detecting phosphorus content in metallurgy raw materials
WO2020148640A3 (en) * 2019-01-15 2020-09-03 Precision Planting Llc Soil analysis compositions and methods

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3123443A (en) * 1960-04-18 1964-03-03 Composition for diagnosing glucose
US3547586A (en) * 1967-06-05 1970-12-15 Jerry W Denney Inorganic phosphate assay,and reagents therefor
US3653836A (en) * 1969-08-27 1972-04-04 Wolfgang Gruher Reagent for determining blood sugar

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3123443A (en) * 1960-04-18 1964-03-03 Composition for diagnosing glucose
US3547586A (en) * 1967-06-05 1970-12-15 Jerry W Denney Inorganic phosphate assay,and reagents therefor
US3653836A (en) * 1969-08-27 1972-04-04 Wolfgang Gruher Reagent for determining blood sugar

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
General Aniline & Film Corp., Tech. Bull., 7543 066; 1960, pp. 1, 4. *
M. M. Davis, National Bur. Standards Monograph, 105, 1968, pp. 17, 19. *
N. D. Cheronis, Organic Chemistry, T. Y. Crowell Co., 1947, pp. 561 562. *
R. J. Henry, Clinical Chemistry, Harper & Row, 1964, pp. 411 413. *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953359A (en) * 1974-04-23 1976-04-27 Pierce Chemical Company Determination of phosphorus
US4220451A (en) * 1979-01-23 1980-09-02 Union Carbide Corporation Process for the determination of serum inorganic phosphate
US4447544A (en) * 1982-07-22 1984-05-08 Instrumentation Laboratory Inc. Method and reagent for determining inorganic phosphate in biological sample
US4731331A (en) * 1984-04-09 1988-03-15 Beckman Instruments, Inc. Rate method for the determination of inorganic phosphorus
US4826773A (en) * 1988-07-18 1989-05-02 Hoffmann-La Roche Inc. Method and reagent for the quantitative determination of phosphorous in serum and urine
EP0404590A3 (en) * 1989-06-22 1991-10-23 Technicon Gmbh Method of and reagent for the prevention of turbidity
CN102879345A (en) * 2012-09-26 2013-01-16 攀钢集团江油长城特殊钢有限公司 Method for determining phosphorus content of silicon ferrovanadium
CN102879345B (en) * 2012-09-26 2015-02-25 攀钢集团江油长城特殊钢有限公司 Method for determining phosphorus content of silicon ferrovanadium
CN104237216A (en) * 2014-06-11 2014-12-24 武汉钢铁(集团)公司 Method for detecting phosphorus content in metallurgy raw materials
WO2020148640A3 (en) * 2019-01-15 2020-09-03 Precision Planting Llc Soil analysis compositions and methods
CN113227786A (en) * 2019-01-15 2021-08-06 精密种植有限责任公司 Soil analysis compositions and methods
US12044665B2 (en) 2019-01-15 2024-07-23 Precision Planting Llc Soil analysis compositions and methods
EP4538713A3 (en) * 2019-01-15 2025-06-25 Precision Planting LLC Soil analyis compositions and methods

Similar Documents

Publication Publication Date Title
Itaya et al. A new micromethod for the colorimetric determination of inorganic phosphate
Nelson A photometric adaptation of the Somogyi method for the determination of glucose
Sastry et al. Spectrophotometric methods for the determination of omeprazole in bulk form and pharmaceutical formulations
US3853469A (en) Reagent and method for phosphorus determination
Lehmann Light-A source of error in the fluorometric determination of tryptophan
Bundgaard Spectrophotometric determination of ampicillin sodium in the presence of its degradation and polymerization products
Jung et al. An improved reagent system for the measurement of serum uric acid
US4412006A (en) Method for determination of nitrate and/or nitrite
US3853473A (en) Reagent and method for urea determination
Wienhausen et al. Properties of bacterial luciferase/NADH: FMN oxidoreductase and firefly luciferase immobilized onto sepharose
Rios et al. Simultaneous flow-injection flourimetric determination of ammonia and hydrazine with a novel mode of forming pH gradients
Cox et al. The measurement of dehydroascorbic acid and diketogulonic acid in normal and diabetic plasma
Mader et al. Polarographic Determination of Folic Acid
CN111239126A (en) Detection reagent combination for phosphate molybdenum antimony resistance method determination and preparation method thereof
US4009004A (en) Reagent and method for determination of phosphorous
US3822115A (en) Method and reagent for uric acid determination
Izquierdo et al. Simultaneous stopped-flow determination of tetracycline and doxycycline in serum based on lanthanide-sensitized luminescence
Klein et al. Application of Fe (II)-5-pyridyl benzodiazepin-2-ones to the determination of serum iron and iron-binding capacity
Mokrasch Spectrophotometric determination of phosphate in the presence of highly labile phosphorus compounds
US3278394A (en) Method and composition for diagnosing glucose
Chen et al. Carbon determination in biological material with persulfate oxidation method
Rho Direct fluorometric determination of urea in urine
EP0404590A2 (en) Method of and reagent for the prevention of turbidity
Kamoun et al. Ultramicromethod for determination of plasma uric acid.
US3615228A (en) Glucose determination method employing orthotoluidine